Product Description
| Brand |
Beckman Coulter |
| Sample Type |
Serum/ Plasma |
| Pack Size |
2 x 50T |
| CAT No. |
A40705 |
Application
|
Torch Panel |
Beckman Coulter Access CMV IgM (CLIA) is a high-performance Chemiluminescent Immunoassay (CLIA) reagent designed for the qualitative determination of IgM antibodies to Cytomegalovirus (CMV) in human serum and plasma. The Access CMV IgM CLIA Reagent delivers high sensitivity, excellent specificity, rapid turnaround time, and reliable results, making it an ideal choice for hospitals, diagnostic laboratories, pathology laboratories, blood banks, transplant centers, and reference laboratories.
Cutting-Edge CMV IgM DetectionThe BC Access CMV IgM (CLIA) test leverages Chemiluminescence Immunoassay technology for superior detection accuracy. Designed for use in professional laboratories, it automates the process of determining IgM antibodies to Cytomegalovirus, ensuring timely and precise results for effective patient management.
Flexible and Portable Laboratory SolutionThanks to its compatibility with automatic CLIA Analyzers and portable design, the BC Access CMV IgM (CLIA) meets the diverse needs of modern laboratories. As a non-wall-mounted device, it allows flexible placement and operation, making it easy to integrate into various laboratory setups.
Reliable Clinical Outcomes Made EasyWith a real-time, automatic operating system, this kit minimizes manual intervention and reduces the possibility of errors. Laboratories benefit from streamlined processes, faster turnaround times, and accessible, actionable reports essential for monitoring CMV infections effectively.
FAQ's of BC Access CMV IgM (CLIA):
Q: How does the BC Access CMV IgM (CLIA) test detect CMV infections?
A: The BC Access CMV IgM (CLIA) test uses Chemiluminescence Immunoassay technology to accurately measure IgM antibodies specific to Cytomegalovirus. This approach ensures reliable detection, assisting clinicians in diagnosing and managing CMV infections early on.
Q: What equipment is required to run the BC Access CMV IgM (CLIA) kit?
A: This test is designed for use with a CLIA Analyzer. Its automatic and real-time operational features streamline laboratory workflows, enabling efficient and consistent analysis of patient specimens.
Q: When should laboratories use the BC Access CMV IgM (CLIA) test?
A: Laboratories should deploy this test when screening for acute or recent Cytomegalovirus infection, particularly in immunocompromised patients, organ transplant recipients, or cases where CMV monitoring is clinically relevant.
Q: Where can I purchase the BC Access CMV IgM (CLIA) kit in India?
A: The BC Access CMV IgM (CLIA) is available through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers throughout India. Contact your preferred distributor for procurement options.
Q: What is the recommended storage condition for the BC Access CMV IgM (CLIA) kit?
A: To maintain optimal performance, store the kit between 2 and 10 degrees Celsius. Avoid freezing or exposing it to temperatures outside this range to preserve reagent stability.
Q: How does using an automatic, real-time CLIA analyzer benefit laboratories?
A: Using an automatic real-time CLIA analyzer reduces manual handling, increases processing speed, and improves result consistency. This enhances diagnostic efficiency and reliability in busy laboratory environments.